Pathway Genomics

OME Care is a privately held global precision medical diagnostic company with mobile applications. Based in San Diego, California, the company offers genetic testing and Artificial Intelligence to physicians for their patients to support treatment a variety of health conditions. The test menu ranges from somatic and hereditary cancer, including BRCA1 and BRCA2, to pharmacogenomics testing for well-known drugs like Plavix, codeine, lamotrigine, to general health and wellness testing which includes information on a number of health conditions including type 1 and type 2 diabetes and hypertension.The company has also applied for an FDA EUA fast-track on a multiplex Covid-19 and Influenza RT-PCR diagnostic test.

OMEcare (OME Wellness) Corporation
TypePrivate
IndustryBiotechnology
Founded2009 (2009)
FounderMichael Nova
Headquarters
San Diego, California
,
United States
Websitewww.pathway.com

OME care owns and operates a clinical laboratory, accredited by the College of American Pathologists (CAP) and Clinical Laboratory Improvement Amendments (CLIA).[1]

History

The company was founded with the vision to make “genetic testing and personalized medicine accessible and affordable to everyone.”[2] OmeCare testing services cover a variety of conditions including somatic & hereditary cancer risk, cardiac health, inherited diseases, nutrition and exercise response, as well as drug response.[3]

In addition to continual testing improvements and new testing developments, OME Care is also currently developing OME. OME is the “world’s only mobile healthcare consumer application with artificial intelligence to help provide consumers with personalized health and wellness information.[4]


As of January 2019, Pathway Genomics was acquired by OME Wellness and re-named OME Care.

IBM Partnership

In 2014, IBM Watson Group announced its partnership with Pathway Genomics, to help “deliver the first-ever cognitive consumer-facing app based on genetics from a user’s personal makeup.”[5] The mobile app, subsequently named OME, is the first of its kind to merge artificial intelligence and deep learning, powered by IBM Watson, with personal genetic information. It provides users with personalized health and wellness information based on the individual’s health history.[6]

Executives

OmeCare’ executives include Vadim Sulman (CEO), Michael Nova, M.D. (Chief Innovation Officer and Founder), Michael Patkin (Vice President of Business Development and Government Relations) and Michael H. Cox, CIPP (Privacy SoCal Privacy Consultants). [7]

See also

Single-nucleotide polymorphism (SNP)
Pharmacogenomics
Genetic counseling
Genomic counseling

References
  1. Licenses/Accreditations. Retrieved August 1, 2015.
  2. [ Michael Nova MD, Founder]. Retrieved July 12, 2015.
  3. Our tests. Retrieved July 7, 2015.
  4. OME Cognitive Mobile Health & Wellness Archived March 4, 2016, at the Wayback Machine. Retrieved August 8, 2015.
  5. IBM Watson Group Invests in Pathway Genomics to Help Personalize Consumer Health Press Release; IBM. Nov 12 2014. Retrieved June 24, 2015.
  6. "OME Cognitive Mobile Health & Wellness Archived March 4, 2016, at the Wayback Machine. Retrieved August 8, 2015.
  7. []. Retrieved May 16, 2016.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.